Cytek Biosciences (CTKB) Other Non Operating Income (2020 - 2026)

Cytek Biosciences (CTKB) has 7 years of Other Non Operating Income data on file, last reported at $565000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income fell 83.82% year-over-year to $565000.0; the trailing twelve-month figure through Mar 2026 stood at $5.9 million (down 17.64% YoY), and the FY2025 full-year result was $8.8 million, up 97.2% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $565000.0, up from $258000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $3.7 million in Q2 2025 and bottomed at -$445000.0 in Q3 2022.
• The 5-year median for Other Non Operating Income is $1.2 million (2023), against an average of $1.3 million.
• The widest annual swing landed in 2022, when Other Non Operating Income sank 111.67%; it then jumped 6184.75% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $2.1 million in 2022, then jumped by 52.75% to $3.2 million in 2023, then plunged by 84.63% to $491000.0 in 2024, then slumped by 47.45% to $258000.0 in 2025, then jumped by 118.99% to $565000.0 in 2026.
• The last three Other Non Operating Income figures came in at $565000.0 (Q1 2026), $258000.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.

Peer Comparison